Use the injection before its expiry date stated on the package
Expert Opin Investig Drugs 32(5):355359 Urva S, Coskun T, Loh MT, Du Y, Thomas MK, Gurbuz S et al (2022) LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial
The most common pre-blended schedule is 0.10 mL (10 units) once daily from a 70 mg vial reconstituted with 3 mL bacteriostatic water
Discussion 1) The study conducted by Nauck et
SCFA activation of the olfactory receptor (Olfr) 78 and the free fatty acid receptor GPR41 causes an increase in blood pressure and a decrease in blood pressure, respectively
How long does it take to lose weight on Ozempic